Related references
Note: Only part of the references are listed.Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
Lanqing Cao et al.
HUMAN PATHOLOGY (2017)
Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas
Mei Liu et al.
LABORATORY INVESTIGATION (2017)
Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma
Keishi Sugimachi et al.
ONCOLOGY (2017)
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis
Maria Teresa Salcedo Allende et al.
PANCREAS (2017)
MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1
Xin Ge et al.
TUMOR BIOLOGY (2017)
Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial-mesenchymal transition
Honglong Wei et al.
TUMOR BIOLOGY (2017)
Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy
Yaowen Zhang et al.
ONCOLOGY LETTERS (2017)
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer
Xiao Zhao et al.
CANCER LETTERS (2017)
Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma
Jakub Klacz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Decreased Expression and Frequent Promoter Hypermethylation of RASSF2 and RASSF6 Correlate With Malignant Progression and Poor Prognosis of Gastric Cardia Adenocarcinoma
Wei Guo et al.
MOLECULAR CARCINOGENESIS (2016)
Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner
Y. Liu et al.
ONCOGENE (2016)
TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer
Yong Zhang et al.
TUMOR BIOLOGY (2016)
LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression
Aibing Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
Toshiro Moroishi et al.
CELL (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
Ping Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma
Mayura Meerang et al.
MOLECULAR ONCOLOGY (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer
Oliver H. Wang et al.
PLOS ONE (2016)
Expression profile and prognostic value of SAV1 in patients with pancreatic ductal adenocarcinoma
Lei Wang et al.
TUMOR BIOLOGY (2016)
Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma
Hao Wu et al.
TUMOR BIOLOGY (2016)
Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine endometrioid adenocarcinoma
Maosheng Zhan et al.
ONCOLOGY LETTERS (2016)
Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients
Rafael H. Abduch et al.
ONCOTARGET (2016)
An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression
Hiromitsu Hayashi et al.
CANCER RESEARCH (2015)
High expression of TAZ indicates a poor prognosis in retinoblastoma
Yiting Zhang et al.
DIAGNOSTIC PATHOLOGY (2015)
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Toshiro Moroishi et al.
GENES & DEVELOPMENT (2015)
Expression of LATS family proteins in ovarian tumors and its significance
Bing Xu et al.
HUMAN PATHOLOGY (2015)
Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma
Yan Guo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
Zhongwu Li et al.
MOLECULAR ONCOLOGY (2015)
YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression
C. He et al.
ONCOGENE (2015)
Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival
Hui-Lin Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Cytoplasmic YAP Expression is Associated with Prolonged Survival in Patients with Lung Adenocarcinomas and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment
Ping-Li Sun et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway
Maolan Li et al.
CANCER LETTERS (2014)
Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma
Wei Guo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Lidan Sun et al.
DIAGNOSTIC PATHOLOGY (2014)
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report
Rehan Akbani et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas
Susan Y. Luo et al.
LUNG CANCER (2014)
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival
Moritz Menzel et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Nuclear expression of phosphorylated TRAF2-and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis
Jing Jin et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
Yan Xia et al.
PLOS ONE (2014)
Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer
Xu-Yong Lin et al.
TUMOR BIOLOGY (2014)
High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosis
Yohei Yoshihama et al.
CANCER SCIENCE (2013)
Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
Lijuan Wang et al.
PLOS ONE (2013)
Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription
Bin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer
Xiaoyan Lin et al.
TUMOR BIOLOGY (2013)
Clinical and prognostic significance of Yes-associated protein in colorectal cancer
Yan Wang et al.
TUMOR BIOLOGY (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
Tianhai Ji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Expression and prognostic significance of MAP4K4 in lung adenocarcinoma
Mei-Hua Qiu et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
Decreased Expression of RASSF6 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Patients after Curative Surgery
Yugang Wen et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
ShRNA-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth
An-Wen Liu et al.
CLINICAL CANCER RESEARCH (2011)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
J. F. Knight et al.
BRITISH JOURNAL OF CANCER (2008)
Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
John J. Liang et al.
CLINICAL CANCER RESEARCH (2008)
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
I. Zlobec et al.
GUT (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis
F Hamaratoglu et al.
NATURE CELL BIOLOGY (2006)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Share Paper
